@KejunYing @GWAS_lit @GWASCatalog @Eric_Fauman Can't remember exactly. I think Jian Yang's team @jyang1981 has done a similar study. https://t.co/Jzs5jPFn2s
The authors of "Tumor mutational burden is polygenic and genetical…" (https://t.co/TyohvqFvay) included RRIDs in their paper! We appreciate the author's support of reproducibility. #ReproducibleResearch #OpenScience
Tumor Mutational Burden Is Polygenic and Genetically Associated with Complex Traits and Diseases https://t.co/vi3Hv9Cq8B
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
TMBは正常さいぼうのmutation burdenのサロゲート、ということか。それにしても多様な因子が関わる。
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
New article: Tumor mutational burden is polygenic and genetically associated with complex traits and diseases. https://t.co/Oyx4wDPt59 #gastriccancer #oncology https://t.co/nUc1oNp62w
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
Excellent work- "our findings support the hypothesis that TMB is not only heritable but also polygenic"
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
RT @jyang1981: This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whol…
This study provides evidence for a polygenic architecture of tumor mutational burden and opens an avenue for the use of whole-genome germline genetic variations to stratify cancer patients for immunotherapy. https://t.co/Esx3n0JQd5